- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 25, 2025 | 119.08M sh |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $279.96M |
| Cash And Equivalents | Q1 2025 · Sep 28, 2024 | $169.73M |
| Cash And Equivalents restated | Q1 2025 · Dec 30, 2023 | $169.73M |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $372.51M |
| Current Liabilities | Q1 2025 · Sep 28, 2024 | $366.15M |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $494.48M |
| Total Liabilities | Q1 2025 · Sep 28, 2024 | $487.69M |
| Current Assets | Q1 2025 · Dec 28, 2024 | $612.53M |
| Current Assets | Q1 2025 · Sep 28, 2024 | $551.09M |
| Total Assets | Q1 2025 · Dec 28, 2024 | $963.61M |
| Total Assets | Q1 2025 · Sep 28, 2024 | $916.31M |
| Shares Diluted | Q1 2025 · Dec 30, 2023 | 126.74M sh |
| Stock Repurchased | Q1 2025 · Dec 30, 2023 | $23.48M |
| Capex | Q1 2025 · Dec 30, 2023 | $6.08M |
| Operating Cash Flow | Q1 2025 · Dec 30, 2023 | $275.4M |
| Stockholders Equity | Q1 2025 · Dec 30, 2023 | $594.41M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $518.66M |
| Eps Diluted | Q1 2025 · Dec 30, 2023 | $0.64 |
| Eps Basic | Q1 2025 · Dec 30, 2023 | $0.65 |
| Sga Expense | Q1 2025 · Dec 30, 2023 | $39.8M |
| Rd Expense | Q1 2025 · Dec 30, 2023 | $79.24M |
| Net Income | Q1 2025 · Dec 30, 2023 | $80.95M |
| Operating Income | Q1 2025 · Dec 30, 2023 | $79.7M |
| Gross Profit | Q1 2025 · Dec 30, 2023 | $282.68M |
| Cost Of Revenue | Q1 2025 · Dec 30, 2023 | $330.19M |
| Revenue | Q1 2025 · Dec 30, 2023 | $612.87M |